METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN
Authors
Keywords
METTL1, PTEN, Prognosis, Hepatocellular carcinoma
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-29
DOI
10.1007/s00109-019-01830-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap
- (2019) Jüri Reimand et al. Nature Protocols
- METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation
- (2019) Luca Pandolfini et al. MOLECULAR CELL
- Transcriptome-wide Mapping of Internal N7-Methylguanosine Methylome in Mammalian mRNA
- (2019) Li-Sheng Zhang et al. MOLECULAR CELL
- Put the Pedal to the METTL1: Adding Internal m7G Increases mRNA Translation Efficiency and Augments miRNA Processing
- (2019) Konstantinos Boulias et al. MOLECULAR CELL
- RNA N6-methyladenosine modification in cancers: current status and perspectives
- (2018) Xiaolan Deng et al. CELL RESEARCH
- RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2
- (2018) Mengnuo Chen et al. HEPATOLOGY
- Mettl1/Wdr4-Mediated m 7 G tRNA Methylome Is Required for Normal mRNA Translation and Embryonic Stem Cell Self-Renewal and Differentiation
- (2018) Shuibin Lin et al. MOLECULAR CELL
- Epitranscriptomic m 6 A Regulation of Axon Regeneration in the Adult Mammalian Nervous System
- (2018) Yi-Lan Weng et al. NEURON
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma
- (2018) Yu-Feng Yang et al. Molecular Cancer
- Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
- (2018) Renumathy Dhanasekaran et al. GASTROENTEROLOGY
- The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells
- (2017) Ly P Vu et al. NATURE MEDICINE
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulatingN6-methyladenosine-dependent primary MicroRNA processing
- (2016) Jin-zhao Ma et al. HEPATOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- KLF4 mediates the link between TGF-β1-induced gene transcription and H3 acetylation in vascular smooth muscle cells
- (2015) Ming He et al. FASEB JOURNAL
- tRNAs: new tricks from old dogs
- (2014) G. Stoecklin et al. EMBO JOURNAL
- tRNA Modifying Enzymes, NSUN2 and METTL1, Determine Sensitivity to 5-Fluorouracil in HeLa Cells
- (2014) Mayumi Okamoto et al. PLoS Genetics
- Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis
- (2013) Jia Fu et al. CANCER SCIENCE
- The yeast rapid tRNA decay pathway competes with elongation factor 1A for substrate tRNAs and acts on tRNAs lacking one or more of several modifications
- (2012) J. M. Dewe et al. RNA
- PTEN and TRP53 Independently Suppress Nanog Expression in Spermatogonial Stem Cells
- (2009) Ewart W. Kuijk et al. STEM CELLS AND DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation